EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways

Manfeng Wang, Meiling Liu, Wanzhen Xu, Zongyan Teng, Xiaowei Wu, Lu Gan, Yina Zhang

Advances in Clinical and Experimental Medicine · 2022

DOI: 10.17219/acem/155342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2022. Verfasst von Manfeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Second Affiliated Hospital of Harbin Medical University, China. Hauptthemen laut MEDLINE: Sarcopenia, Sepsis. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaSepsisMiceAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinLipopolysaccharidesToll-Like Receptor 4Cell DifferentiationInflammationMyoblastsSulfoxidesIsothiocyanates

Stichwörter der Autor:innen

C2C12LPSTLR4-NLRP3 pathwaysepsissulforaphane

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinLipopolysaccharidesToll-Like Receptor 4sulforaphaneSulfoxidesIsothiocyanatesNlrp3 protein, mouse

Autor:innen und Institutionen

  • Department of Geriatrics, Second Affiliated Hospital of Harbin Medical University, China.
  • Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China.

Zitieren

APA

Wang, M., Liu, M., Xu, W., Teng, Z., Wu, X., Gan, L., & Zhang, Y. (2022). Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/155342

Vancouver

Wang M, Liu M, Xu W, Teng Z, Wu X, Gan L, et al. Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways. Advances in Clinical and Experimental Medicine. 2022. doi:10.17219/acem/155342

BibTeX
@article{Wang2022,
  author = {Wang, Manfeng and Liu, Meiling and Xu, Wanzhen and Teng, Zongyan and Wu, Xiaowei and Gan, Lu and Zhang, Yina},
  title = {Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2022},
  doi = {10.17219/acem/155342}
}
Kostenlos starten →